Park Jimyung, Lee Yeon Joo, Lee Jinwoo, Park Sung Soo, Cho Young-Jae, Lee Sang-Min, Kim Young Whan, Han Sung Koo, Yoo Chul-Gyu
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
Korean J Intern Med. 2018 May;33(3):532-540. doi: 10.3904/kjim.2016.346. Epub 2017 Nov 1.
BACKGROUND/AIMS: Diffuse alveolar damage (DAD) is the histopathologic hallmark of acute respiratory distress syndrome (ARDS). However, there are several non-DAD conditions mimicking ARDS. The purpose of this study was to investigate the histopathologic heterogeneity of ARDS revealed by surgical lung biopsy and its clinical relevance.
We retrospectively analyzed 84 patients with ARDS who met the criteria of the Berlin definition and underwent surgical lung biopsy between January 2004 and December 2013 in three academic hospitals in Korea. We evaluated their histopathologic findings and compared the clinical outcomes. Additionally, the impact of surgical lung biopsy on therapeutic alterations was examined.
The histopathologic findings were highly heterogeneous. Of 84 patients undergoing surgical lung biopsy, DAD was observed in 31 patients (36.9%), while 53 patients (63.1%) did not have DAD. Among the non-DAD patients, diffuse interstitial lung diseases and infections were the most frequent histopathologic findings in 19 and 17 patients, respectively. Although the mortality rate was slightly higher in DAD (71.0%) than in non-DAD (62.3%), the difference was not significant. Overall, the biopsy results led to treatment alterations in 40 patients (47.6%). Patients with non-DAD were more likely to change the treatment than those with DAD (58.5% vs. 29.0%), but there were no significant improvements regarding the mortality rate.
The histopathologic findings of ARDS were highly heterogeneous and classic DAD was observed in one third of the patients who underwent surgical lung biopsy. Although therapeutic alterations were more common in patients with non-DAD-ARDS, there were no significant improvements in the mortality rate.
背景/目的:弥漫性肺泡损伤(DAD)是急性呼吸窘迫综合征(ARDS)的组织病理学标志。然而,有几种非DAD情况可模仿ARDS。本研究的目的是调查经手术肺活检揭示的ARDS的组织病理学异质性及其临床相关性。
我们回顾性分析了2004年1月至2013年12月期间在韩国三家学术医院符合柏林定义标准并接受手术肺活检的84例ARDS患者。我们评估了他们的组织病理学发现并比较了临床结果。此外,还检查了手术肺活检对治疗改变的影响。
组织病理学发现高度异质性。在84例接受手术肺活检的患者中,31例(36.9%)观察到DAD,而53例(63.1%)没有DAD。在非DAD患者中,弥漫性间质性肺疾病和感染分别是19例和17例患者中最常见的组织病理学发现。虽然DAD患者的死亡率(71.0%)略高于非DAD患者(62.3%),但差异不显著。总体而言,活检结果导致40例患者(47.6%)的治疗发生改变。非DAD患者比DAD患者更有可能改变治疗(58.5%对29.0%),但死亡率没有显著改善。
ARDS的组织病理学发现高度异质性,在接受手术肺活检的患者中有三分之一观察到典型的DAD。虽然非DAD-ARDS患者的治疗改变更常见,但死亡率没有显著改善。